Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
View Patent ↗Methods for alleviating pain comprising administering to a subject sphingosine-1-phosphate, functional fragments and derivatives thereof, and other compounds, and assays for identifying such compounds.
1. A method of alleviating pain associated with nociceptive processing or sensitization in the spinal cord and dorsal root ganglia, the method comprising administering to a subject experiencing pain a compound that activates a sphingosine-1-phosphate receptor in the spinal cord or dorsal root ganglia or enhances PAM (protein associated with Myc) activity in the spinal cord or dorsal root ganglia, wherein the compound is sphingosine-1-phosphate or a salt thereof or FTY 720 or a salt thereof, thereby alleviating pain associated with nociceptive processing or sensitization in the spinal cord and dorsal root ganglia in the subject.
2. The method of claim 1 , wherein the compound is administered intrathecally.
3. The method of claim 1 , wherein the compound is administered intravenously.
4. The method of claim 1 , wherein the compound is administered orally.
5. The method of claim 1 , wherein the subject is a mammal.
6. The method of claim 5 , wherein the mammal is a human.
7. The method of claim 1 , wherein the compound is sphingosine-1-phosphate or a salt thereof.
8. The method of claim 7 , wherein the compound is administered intrathecally.
9. The method of claim 7 , wherein the compound is administered intravenously.
10. The method of claim 7 , wherein the compound is administered orally.
11. The method of claim 7 , wherein the subject is a mammal.
12. The method of claim 11 , wherein the mammal is a human.
13. The method of claim 1 , wherein the compound is FTY 720 or a salt thereof.
14. The method of claim 13 , wherein the compound is administered intrathecally.
15. The method of claim 13 , wherein the compound is administered intravenously.
16. The method of claim 13 , wherein the compound is administered orally.
17. The method of claim 13 , wherein the subject is a mammal.
18. The method of claim 17 , wherein the mammal is a human.
19. The method of claim 1 , wherein the pain is nociceptive pain.
20. The method of claim 19 , wherein the nociceptive pain is chronic nociceptive pain.
21. The method of claim 19 , wherein the nociceptive pain is acute nociceptive pain.